The regulatory landscape for cell therapies is rapidly evolving, creating both challenges and opportunities for developers to move from clinical to commercial success. Staying ahead requires not only awareness of current global expectations but also the ability to proactively respond to regulatory updates and build a strong Chemistry, Manufacturing, and Controls (CMC) and analytical framework early in development. This webinar will outline key elements that support a successful manufacturing and regulatory strategy, including the use of phase appropriate standards, implementation of advanced analytics, establishment of robust process validation criteria, and effective management of product comparability. The webinar will also explore practical approaches to strengthen commercial readiness and ensure that cell therapy products meet safety, efficacy, and quality expectations while accelerating their path to approval and patient access.